FDA Enforcement Class II Ongoing

PulseSpray Infusion System devices including: PULSE SPRAY 5F/135/20, UPN: H787125004045, REF: 12500404; Pulse Spray 3Fx135x20, UPN: H787125004155, REF: 12500415; and PULSE SPRAY 5F/45/10, UPN: H787125004235, REF: 12500423.

Recall: Z-1010-2024 · Reported February 14, 2024

Enforcement

Recall Number
Z-1010-2024
Event ID
93744
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Angiodynamics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 14, 2024
Initiation Date
December 18, 2023
Classification Date
February 7, 2024
Address
603 Queensbury Ave, Queensbury, NY, 12804-7619, United States

Description

PulseSpray Infusion System devices including: PULSE SPRAY 5F/135/20, UPN: H787125004045, REF: 12500404; Pulse Spray 3Fx135x20, UPN: H787125004155, REF: 12500415; and PULSE SPRAY 5F/45/10, UPN: H787125004235, REF: 12500423.

Reason

Rotating adaptor O-ring manufacturing defect impacting seal integrity which may lead to a leak during infusion of medication.

Code Info

UDI-DI: 15051684013109, REF: 12500404, Lot: 5795345; UDI-DI: 15051684013215, REF: 12500415, Lot: 5793480; UDI-DI: 15051684013291, REF: 12500423, Lot: 5795344.

Distribution

United States (MD, LA & UT), Austria, Canada and Spain.

Quantity

7 eaches